Visiongain Report Looks at Opportunities within the $355bn Drug Delivery Technologies Market

LONDON, April 1, 2019 /PRNewswire/ -- The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures – all unavailable elsewhere.

The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Drug Delivery Technologies market forecasts from 2019-2029

• Drug Delivery Technologies submarket forecasts from 2019-2029 covering:

• Oral Drug Delivery Technology
• Inhalable Drug Delivery Technology
• Injectable/Implantable Drug Delivery Technology
• Transdermal Drug Delivery Technology
• Ocular Drug Delivery Technology
• Nasal/Buccal Drug Delivery Technology

This report discusses the drivers and restraints of each submarket.

• Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering:

• North America: US, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
• Latin America: Brazil and Rest of Latin America
• Rest of the World: Middle East, Africa

• Assessment of the leading companies in the Drug Delivery Technologies market:
• 3M
• Alkermes PLC
• Altea Therapeutics Corporation
• Antares Pharma Inc.
• Applied Pharma Research S.A. (APR)
• Becton, Dickinson & Company
• Ethypharm SA
• Glycologic Limited
• Intercell AG
• NanoPass Technologies Ltd.
• pSivida

• SWOT analysis of the drug delivery technologies market

Visiongain's study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.

Buy our report today Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/drug-delivery-technologies-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

3M
Alexza Pharmaceuticals
Alkermes
Altea Therapeutics Corporation
Alza
Antares Pharma Inc.
Applied Pharma Research S.A. (APR)
Aradigm
AstraZeneca
Bayer HealthCare Pharmaceuticals
Becton, Dickinson and Company
Biogen Idec
Bristol-Myers Squibb
C.R. Bard, Inc.
Caesarea Medical Electronics (CME)
CareFusion Corporation
Cima Labs
Clearside Biomedical
Cosmo Pharmaceuticals
CRISI Medical Systems
Eli Lilly
Ethypharm SA
Ferrer
Flamel
Genentech
Generex
Glycologic Limited
Google
IDRI
ImmusanT
Innovent Biologics
Insmed
Intercell AG
iScience Interventional Corporation
J&J
MannKind
Medimetrics
MedImmune
Merck Serono
Mucosis
NanoPass Technologies Ltd.
Nektar Therapeutics
NHTherapeutics
Nitto Denko
Novo Nordisk
NuPathe
Oramed Pharmaceuticals
Pari Pharma
Pfizer
PharmaJet
Phoenix Solutions AS
pSivida
Rani Therapeutics
Renhe Group
Sandoz
Sanofi-Aventis
Santen
Spark Therapeutics
Teva
Transdermal Specialties
VentureHealth

Organizations Mentioned in the Report
Australia Institute of Health and Welfare
Bill & Melinda Gates Foundation
Center for Disease Control and Prevention (CDC)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center for Drug Evaluation and Research (CDER)
Emory University School of Medicine
Food and Drug Administration (FDA)
Georgia Institute of Technology
International Diabetes Federation
Japan's Ministry of Health, Labour, and Welfare (MHLW)
JDRF
The Center for Drug Evaluation (CDE)
The European Medicines Agency (EMA)
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on [email protected]

SOURCE Visiongain